{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:48:59Z","timestamp":1792759739091,"version":"4.5.0"},"reference-count":74,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["02.a03.0008"],"award-info":[{"award-number":["02.a03.0008"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,1,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Platelet-rich plasma (PRP) found its use in treating different conditions and diseases, because concentrated plasma PRP consists of many growth factors. Their interaction with surrounding cells, intracellular matrix, and mediators at the site of injection leads to tissue regeneration. Angiogenic, vasculogenic, and regenerative effects of PRP may be used for erectile dysfunction (ED) and Peyronie\u2019s disease (PD) treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To present a current data review of preclinical and clinical trials on PRP use for treating ED and PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Up-to-date literature on PRP use for ED and PD treatment was analyzed. The search was based on Pubmed, Cochrane Library, clinicaltrials.gov databases, with the following key words: \u201cplatelet-rich plasma\u201d and\/or \u201cerectile dysfunction\u201d and\/or \u201cPeyronie\u2019s disease\u201d and\/or \u201csexual dysfunction.\u201d<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures<\/jats:title>\n                    <jats:p>The main outcome measures for preclinical trials on ED were erectile function, assessed with intracavernous pressure, and pathologic analysis of penile tissue. The main outcome measures for clinical trials on ED included penile duplex Doppler ultrasound scanning and validated questionnaires. The main outcome measures on PD were pathologic analysis of penile tissue for preclinical trials, as well as penile duplex Doppler ultrasound scanning, penile curvature angle measuring, and validated questionnaires for clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>4 preclinical and 6 clinical trials were described and analyzed in this article. Limitations for both preclinical and clinical trials included small groups, short follow-up periods, a lack of control groups or groups with placebo, and the lack of quality and quantity analysis of PRP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Available data show the lack of adverse reactions with PRP treatment. The studies that we found were limited by small groups. This is why the data on safety and effectiveness should be taken carefully. However, it is important to mention that PRP therapy has the potential for treating male sexual dysfunction and may be useful in andrology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.sxmr.2019.02.002","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T10:34:38Z","timestamp":1552991678000},"page":"106-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Platelet-Rich Plasma Therapy for Male Sexual Dysfunction: Myth or Reality?"],"prefix":"10.1093","volume":"8","author":[{"given":"Maya V.","family":"Epifanova","sequence":"first","affiliation":[{"name":"Department of Urology and Operative Nephrology with Oncourology course of the Medical Institute of Peoples\u2019 Friendship University (RUDN University) , Moscow , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badri R.","family":"Gvasalia","sequence":"additional","affiliation":[{"name":"Department of Urology with Oncology, Radiology and Andrology courses of the Continuing Medical Education of of Peoples\u2019 Friendship University (RUDN University) , Moscow , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksim A.","family":"Durashov","sequence":"additional","affiliation":[{"name":"Sechenov University , Moscow , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey A.","family":"Artemenko","sequence":"additional","affiliation":[{"name":"Sechenov University , Moscow , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5021\/ad.2011.23.4.424","article-title":"Can platelet-rich plasma be used for skin rejuvenation? Evaluation of effects of platelet-rich plasma on human dermal fibroblast","volume":"23","author":"Kim","year":"2011","journal-title":"Ann Dermatol"},{"key":"2023041308054315500_","first-page":"530","article-title":"Platelet-rich plasma: Quantitative assessment of growth factor levels and comparative analysis of activated and inactivated groups","volume":"40","author":"Lee","year":"2013","journal-title":"Arch PlastSurg"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/DSS.0000000000001083","article-title":"Autologous pure platelet-rich plasma dermal injections for facial skin rejuvenation: Clinical, instrumental, and flow cytometry assessment","volume":"43","author":"Cameli","year":"2017","journal-title":"Dermatol Surg"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3109\/02713683.2015.1104362","article-title":"Plasma rich in growth factors for the treatment of ocular surface diseases","volume":"41","author":"Anitua","year":"2016","journal-title":"Curr Eye Res"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1177\/0363546515624678","article-title":"Intra-articular autologous conditioned plasma injections provide safe and efficacious treatment for knee osteoarthritis: An FDA-sanctioned, randomized, double-blind, placebo-controlled clinical trial","volume":"44","author":"Smith","year":"2016","journal-title":"Am J Sports Med"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s00167-010-1238-6","article-title":"Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis","volume":"19","author":"Filardo","year":"2011","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1177\/0363546509349921","article-title":"Platelet-rich plasma from basic science to clinical applications","volume":"37","author":"Foster","year":"2009","journal-title":"Am J Sports Med"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13019-016-0452-9","article-title":"Evaluation of autologous platelet rich plasma for cardiac surgery: outcome analysis of 2000 patients","volume":"11","author":"Patel","year":"2016","journal-title":"J Cardiothorac Surg"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/edt.12021","article-title":"Effect of autologous platelet-rich plasma on bone regeneration in mandibular fractures","volume":"29","author":"Daif","year":"2013","journal-title":"Dent Traumatol"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10006-017-0609-2","article-title":"Immediate post-extraction implants with or without pure platelet-rich plasma: A 5-year follow-up study","volume":"21","author":"Taschieri","year":"2017","journal-title":"Oral Maxillofac Surg"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.msec.2016.10.001","article-title":"Fabrication and characterization of platelet-rich plasma scaffolds for tissue engineering applications","volume":"71","author":"Sadeghi-Ataabadi","year":"2017","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/ijd.12162","article-title":"Sensory improvement of leprosy peripheral neuropathy in patients treated with perineural injection of platelet-rich plasma","volume":"53","author":"Anjayani","year":"2014","journal-title":"Int J Dermatol"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.kjms.2016.11.005","article-title":"Effect of platelet-rich plasma on reconstruction with nerve autografts","volume":"33","author":"Teymur","year":"2017","journal-title":"Kaohsiung J Med Sci"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1002\/jcp.25721","article-title":"Generation of insulin-producing cells from human-induced pluripotent stem cells using a stepwise differentiation protocol optimized with platelet-rich plasma","volume":"232","author":"Enderami","year":"2017","journal-title":"J Cell Physiol"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.avsg.2016.04.023","article-title":"Platelet rich plasma for the treatment of clean diabetic foot ulcers","volume":"38","author":"Ahmed","year":"2017","journal-title":"Ann Vasc Surg"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/0974-2077.150734","article-title":"Principles and methods of preparation of platelet-rich plasma: A review and author\u2019s perspective","volume":"7","author":"Dhurat","year":"2014","journal-title":"J Cutan Aesthet Surg"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000477353","article-title":"A review of platelet-rich plasma: history, biology, mechanism of action, and classification","volume":"4","author":"Alves","year":"2018","journal-title":"Skin Appendage Disord"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"41","DOI":"10.25083\/2559.5555.12.16","article-title":"(2016). Platelet rich plasma\u2014Mechanism of action and clinical applications","volume":"1","author":"Cozma","year":"2016","journal-title":"J Clin Investigative Surg"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tibtech.2008.11.009","article-title":"Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)","volume":"2","author":"Dohan Ehrenfest","year":"2009","journal-title":"Trends Biotechnol"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":"Vascular endothelial growth factor and angiogenesis","volume":"56","author":"Hoeben","year":"2004","journal-title":"Pharmacol Rev"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/ph3030572","article-title":"Platelet-derived growth factor (PDGF)\/PDGF receptors (PDGFR) axis as target for antitumor and antiangiogenic therapy","volume":"3","author":"Raica","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MOH.0b013e3282f97d98","article-title":"Fibroblast growth factor regulation of neovascularization","volume":"15","author":"Murakami","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/ijc.21479","article-title":"Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategies","volume":"117","author":"van Cruijsen","year":"2005","journal-title":"Int J Cancer"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1074\/jbc.M114.634154","article-title":"Insulin-like growth factor 1 (IGF-1) stabilizes nascent blood vessels","volume":"290","author":"Jacobo","year":"2015","journal-title":"J Biol Chem"},{"key":"2023041308054315500_","article-title":"Epidemiology of ED","author":"Boston University School of Medicine"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/j.1743-6109.2012.02976.x","article-title":"The Global Online Sexuality Survey (GOSS): the United States of America in 2011. Chapter I: erectile dysfunction among English-speakers","volume":"9","author":"Shaeer","year":"2012","journal-title":"J Sex Med"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"111","DOI":"10.21608\/ha.2017.1788.1015","article-title":"The Global Online Sexuality Survey (GOSS) 2015: Erectile dysfunction among English-speaking internet users in the United States","volume":"7","author":"Shaeer","year":"2017","journal-title":"Human Androl"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.ijir.3900328","article-title":"Is there a role of hypoxemia in penile brosis: a viewpoint presented to the Society for the Study of Impotence","volume":"10","author":"Moreland","year":"1998","journal-title":"Int J Impot Res"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.aju.2011.03.013","article-title":"Reversion of penile fibrosis: Current information and a new horizon","volume":"9","author":"El-Sakka","year":"2011","journal-title":"Arab J Urol"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11357-010-9167-3","article-title":"Erectile tissue molecular alterations with aging\u2014differential activation of the p42\/44 MAP Kinase pathway","volume":"33","author":"Castela","year":"2011","journal-title":"Age"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1111\/j.1743-6109.2010.01792.x","article-title":"Erectile dysfunction and risk of clinical cardiovascular events: A meta-analysis of seven cohort studies","volume":"7","author":"Guo","year":"2010","journal-title":"J Sex Med"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1001\/jama.294.23.2996","article-title":"Erectile dysfunction and subsequent cardiovascular disease","volume":"294","author":"Thompson","year":"2005","journal-title":"JAMA"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1111\/jsm.13032","article-title":"Erectile dysfunction and mortality in a national prospective cohort study","volume":"12","author":"Loprinzi","year":"2015","journal-title":"J Sex Med"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sexol.2018.01.017","article-title":"La dysfonction \u00e9rectile, une pr\u00e9sence active","volume":"27","author":"Colson","year":"2018","journal-title":"Sexologies"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/ageing\/25.4.285","article-title":"Sexual desire, erection, orgasm and ejaculatory functions and their importance to elderly Swedish men: A population-based study","volume":"25","author":"Helgason","year":"1996","journal-title":"Age Ageing"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.2337\/dc10-0524","article-title":"Sexuality among middle-aged and older adults with diagnosed and undiagnosed diabetes: A national, population-based study","volume":"33","author":"Lindau","year":"2010","journal-title":"Diabetes Care"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.juro.2018.05.004","article-title":"Erectile Dysfunction: AUA Guidline","volume":"200","author":"Burnett","year":"2018","journal-title":"J Urol"},{"key":"2023041308054315500_","article-title":"European Association of Urology Guidelines 2018 edition","author":"EAU","year":"2018"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","article-title":"Peyronie's Disease: AUA Guideline","volume":"194","author":"Nehra","year":"2015","journal-title":"J Urol"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-5347(17)35997-9","article-title":"Penile vascular evaluation of men with Peyronie\u2019s disease","volume":"149","author":"Lopez","year":"1993","journal-title":"J Urol"},{"key":"2023041308054315500_","first-page":"93","article-title":"Peyronie\u2019s disease: medical and surgical management","author":"Carson","year":"1999","journal-title":"Handbook of Sexual Dysfunction"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"46","DOI":"10.21037\/tau.2016.11.01","article-title":"Understanding the cellular basis and pathophysiology of Peyronie\u2019s disease to optimize treatment for erectile dysfunction","volume":"6","author":"Campbell","year":"2017","journal-title":"Transl Androl Urol"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","article-title":"Peyronie's disease: AUA guideline","volume":"194","author":"Nehra","year":"2015","journal-title":"J Urol"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/S0022-5347(05)67616-1","article-title":"A rat model of Peyronie\u2019s disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression","volume":"163","author":"Bivalacqua","year":"2000","journal-title":"J Urol"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11934-000-0010-8","article-title":"Peyronie\u2019s disease: Advances in basic science and pathophysiology","volume":"1","author":"Bivalacqua","year":"2000","journal-title":"Curr Urol Rep"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11930-015-0045-y","article-title":"Peyronie\u2019s disease: A review of etiology, diagnosis, and management","volume":"7","author":"Bilgutay","year":"2015","journal-title":"Curr Sex Health Rep"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1464-410x.1998.00529.x","article-title":"Histological and ultrastructural alterations in an animal model of Peyronie\u2019s disease","volume":"181","author":"El-Sakka","year":"1998","journal-title":"Br J Urol"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0022-5347(01)64223-X","article-title":"Peyronie\u2019s disease is associated with an increase in transforming growth factor beta protein expression","volume":"158","author":"El-Sakka","year":"1997","journal-title":"J Urol"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0022-5347(01)68236-3","article-title":"An animal model of Peyronie\u2019s-like condition associated with an increase of transforming growth factor beta mRNA and protein expression","volume":"158","author":"El-Sakka","year":"1997","journal-title":"J Urol"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"e13051","DOI":"10.1111\/and.13051","article-title":"Reduction in Peyronie's-like plaque size using a vacuum erection device in a rat model of Peyronie\u2019s disease via the TGF-\u03b2\/SMAD signaling pathway","volume":"50","author":"Li","year":"2018","journal-title":"Andrologia"},{"key":"2023041308054315500_","article-title":"Intratunical injection of stromal vascular fraction prevents fibrosis in a rat model of Peyronie\u2019s disease","author":"Castiglione","year":"2018","journal-title":"BJU Int"},{"key":"2023041308054315500_","article-title":"The effect of platelet-rich plasma on Peyronie\u2019s disease in rat model","author":"Culha","year":"2018","journal-title":"Urol Int"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase Clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"380","DOI":"10.23736\/S0393-2249.18.03118-1","article-title":"Collagenase clostridium histolyticum: A novel medical treatment for Peyronie\u2019s disease","volume":"70","author":"Abdel Raheem","year":"2018","journal-title":"Minerva Urol Nefrol"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15761\/SHI.1000102","article-title":"Evaluation of the benefit of using a combination of autologous platelet rich-plasma and hyaluronic acid for the treatment of Peyronie\u2019s disease","volume":"1","author":"Virag","year":"2017","journal-title":"Sex Health Issues"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0029-1242033","article-title":"Applications of platelet-rich fibrin matrix in facial plastic surgery","volume":"25","author":"Sclafani","year":"2009","journal-title":"Facial Plast Surg"},{"key":"2023041308054315500_","first-page":"150","article-title":"Evaluation of the effects of platelet-rich plasma (PRP) therapy involved in the healing of sports-related soft tissue injuries","volume":"32","author":"Middleton","year":"2012","journal-title":"Iowa Orthop J"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4081\/aiua.2016.4.274","article-title":"The use of autologous platelet rich plasma gel in bulbar and penile buccal mucosa urethroplasty: Preliminary report of our first series","volume":"88","author":"Scarcia","year":"2016","journal-title":"Arch Ital Urol Androl"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/aja.2008.37","article-title":"The effect of platelet-rich plasma on cavernous nerve regeneration in a rat model","volume":"11","author":"Ding","year":"2009","journal-title":"Asian J Androl"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1111\/j.1743-6109.2012.02881.x","article-title":"The neuroprotective effect of platelet-rich plasma on erectile function in bilateral cavernous nerve injury rat model","volume":"9","author":"Wu","year":"2012","journal-title":"J Sex Med"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"E294","DOI":"10.1002\/term.1806","article-title":"Optimization of platelet-rich plasma and its effects on the recovery of erectile function after bilateral cavernous nerve injury in a rat model","volume":"10","author":"Wu","year":"2016","journal-title":"J Tissue Eng Regen Med"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4111\/icu.2018.59.1.61","article-title":"Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions","volume":"59","author":"Matz","year":"2018","journal-title":"Investig Clin Urol"},{"key":"2023041308054315500_","first-page":"76","article-title":"The effectiveness of intracavernous autologous platelet-rich plasma in the treatment of erectile dysfunction","author":"Chalyj","year":"2015","journal-title":"Urologiia"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"46","DOI":"10.18565\/urology.2017.4.46-48","article-title":"Investigation of mechanisms of action of growth factors of autologous platelet-rich plasma used to treat erectile dysfunction","author":"Epifanova","year":"2017","journal-title":"Urologiia"},{"issue":"Suppl. 4S","key":"2023041308054315500_","first-page":"e582","article-title":"MP43-09 Effects of platelet rich plasma on improving erectile dysfunction in streptozotocin-induced diabetic rats","volume":"199","author":"Liao","year":"2018","journal-title":"the journal of urology"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jsxm.2016.11.174","article-title":"Combined treatment of injecting platelet rich plasma with vacuum pump for penile enlargement","volume":"14","author":"Kumar","year":"2017","journal-title":"J Sex Med"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.jsxm.2016.12.134","article-title":"The efficacy of platelet-rich plasma (PRP) as a supplemental therapy for the treatment of erectile dysfunction (ED): Initial outcomes","volume":"14","author":"Banno","year":"2017","journal-title":"J Sex Med"},{"issue":"Suppl. 3","key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1016\/j.jsxm.2018.04.283","article-title":"Corporeal rejuvenation with platelet rich plasma as a treatment for erectile dysfunction","volume":"15","author":"Alkhayal","year":"2018","journal-title":"J Sex Med"},{"key":"2023041308054315500_","first-page":"96","article-title":"A new treatment of LaPeyronie\u2019s disease by local injections of plasma rich platelets (PRP) and hyaluronic acid. Preliminary results","volume":"13","author":"Virag","year":"2014","journal-title":"E-m\u00e9moires de l'Acad\u00e9mie Nationale de Chirurgie"},{"key":"2023041308054315500_"},{"issue":"Suppl","key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jsxm.2016.02.013","article-title":"Ultrasound guided treatment of Peyronie\u2019s disease with plasma rich platelets (PRP) and hyaluronic acid (HA)","volume":"13","author":"Virag","year":"2016","journal-title":"J Sex Med"},{"issue":"Suppl","key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/j.jsxm.2017.03.112","article-title":"Plasma rich platelets and hyaluronic acid improves Peyronie's disease: A case control study of 75 cases","volume":"14","author":"Virag","year":"2017","journal-title":"J Sex Med"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnins.2018.00252","article-title":"Therapeutic effect of platelet-rich plasma in rat spinal cord injuries","volume":"12","author":"Chen","year":"2018","journal-title":"Front Neurosci"},{"key":"2023041308054315500_","doi-asserted-by":"crossref","first-page":"e67303","DOI":"10.1371\/journal.pone.0067303","article-title":"HGF mediates the anti-inflammatory effects of PRP on injured tendons","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS ONE"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052119300083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052119300083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/8\/1\/106\/49873249\/smr_8_1_106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/8\/1\/106\/49873249\/smr_8_1_106.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T13:17:43Z","timestamp":1694697463000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smr\/article\/8\/1\/106\/6812655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,3,19]]},"published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.sxmr.2019.02.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739215741.793581513","asserted-by":"object"}]},"ISSN":["2050-0521","2050-0513"],"issn-type":[{"value":"2050-0521","type":"electronic"},{"value":"2050-0513","type":"print"}],"subject":[],"published-other":{"date-parts":[[2020,1]]},"published":{"date-parts":[[2019,3,19]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet-Rich Plasma Therapy for Male Sexual Dysfunction: Myth or Reality?","name":"articletitle","label":"Article Title"},{"value":"Sexual Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sxmr.2019.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}